- Have any questions?
- +88-01714063309
- info@bdix.net
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants (Science Direct)
Coronavirus Pandemic Country Data (August 23, 2020)
August 24, 2020U.S. Embassy Provides COVID-19 Response Equipment to Dhaka Metropolitan Police Diplomatic Security Division (US Embassy in Bangladesh)
August 24, 2020Science Direct
International Journal of Antimicrobial Agents
24 August, 2020
Lucy Catteau PharmD, PhD, Nicolas Dauby MD, PhD, Marion Montourcy MSc, Emmanuel Bottieau MD, PhD, Joris Hautekiet MSc, Els Goetghebeur PhD, Sabrinavan Ierssel MD, PhD, Els Duysburgh MD, MPH, PhD, Herman Van Oyen MD, DrPH, Chloé Wyndham-Thomas MD, PhD, Dominique Van Beckhoven MD, MSc, Belgian Collaborative Group on COVID-19 hospital surveillance
24 August, 2020
Hydroxychloroquine (HCQ) has been largely used and investigated as therapy of COVID-19 across various settings, at total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (2400 mg in total over five days) was recommended for hospitalized patients with COVID-19.
Source: https://www.sciencedirect.com/science/article/pii/S0924857920303423